Stockreport

Is bluebird bio One Step Closer to Its First Commercial Drug? [The Motley Fool]

bluebird bio, Inc.  (BLUE) 
Last bluebird bio, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.bluebirdbio.com/investor-overview
PDF Interim results for one of its lead gene therapies could suggest an approval in the future Beta thalassemia patients endure a lifetime of blood transfusions that [Read more]